ctdna as a biomarker for post-resection colorectal cancer recurrence
Published 11 months ago • 275 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
0:39
the future of ctdna as an indicator of colorectal cancer recurrence at esmo 2023
-
0:35
how can ctdna be used as a biomarker for colon cancer?
-
1:02
galaxy: ctdna as a prognostic biomarker in resected colorectal cancer
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
1:09
ctdna mrd as a biomarker for solid tumors
-
0:45
the emerging role of ctdna in cancer diagnostics
-
4:31
cobra: ctdna to help decide which patients with colon cancer will benefit from adjuvant chemotherapy
-
30:04
allycon 2021: how ctdna is used in colorectal cancer recurrence monitoring
-
2:13
ongoing clinical trials on using ctdna results to guide gi cancer management
-
3:16
the utility of ctdna in colorectal cancer management
-
1:57
ctdna, a biomarker of residual disease and tumor response in gastrointestinal cancers
-
25:08
is my treatment working? using ctdna to optimize the management of colorectal cancer
-
6:22
utilising ctdna in oncology
-
6:58
personalizing ctdna analysis to predict crc relapse
-
3:48
using ctdna to guide adjuvant therapy in stage ii colorectal cancer
-
2:01
pre-treatment ctdna linked to increased risk of early recurrence in io-treated melanoma
-
0:53
how can ctdna be used to monitor outcomes in colorectal cancer?
-
34:17
colorectal cancer breakout: biomarkers for effective treatment
-
4:26
fundamentals of ctdna